GH Research (GHRS) Beginning Cash Balance (2022 - 2025)

GH Research (GHRS) Beginning Cash Balance (2022 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 GH Research 2.02 Bn 1.68 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 100.79 Mn
Dec 31, 2025 100.79 Mn
Dec 31, 2024 78.42 Mn
Dec 31, 2024 78.42 Mn
Dec 31, 2023 165.96 Mn
Dec 31, 2023 165.96 Mn
Dec 31, 2022 276.78 Mn
Dec 31, 2022 276.78 Mn